Starting in October 2025, patients in the U.S. without insurance will be able to buy certain AstraZeneca drugs directly from the company’s new online pharmacy, AstraZeneca Direct. This service will offer discounts of up to 70% off the usual list prices for medications like Farxiga (used for diabetes and kidney disease) and Airsupra (used for asthma). The Flumist flu vaccine will also be available for home delivery. Farxiga, one of AstraZeneca’s top-selling drugs, costs $599.72 for a month’s supply, while Airsupra costs $489.25 per inhaler. However, AstraZeneca has already capped the monthly cost for inhaled asthma medicines at $35 since June 2025. Joris Silon, AstraZeneca’s U.S. president, said the new platform will make medications more affordable and convenient for patients. This move comes as U.S. drug prices face pressure to lower costs, with President Trump pushing for prices to match those in other developed countries. Other drugmakers, like Bristol Myers Squibb and Novo Nordisk, have also recently launched similar programs to offer cheaper medications directly to patients.